| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria, Falciparum | 14 | 2023 | 90 | 5.870 |
Why?
|
| Antibodies, Protozoan | 12 | 2023 | 82 | 4.000 |
Why?
|
| Antigens, Protozoan | 11 | 2023 | 74 | 3.940 |
Why?
|
| Plasmodium falciparum | 11 | 2023 | 144 | 3.750 |
Why?
|
| Campylobacter jejuni | 11 | 2009 | 22 | 2.220 |
Why?
|
| Plasmids | 12 | 2009 | 244 | 2.170 |
Why?
|
| Conjugation, Genetic | 11 | 2008 | 14 | 1.940 |
Why?
|
| Helicobacter pylori | 12 | 2010 | 118 | 1.790 |
Why?
|
| Drug Resistance, Bacterial | 12 | 2017 | 90 | 1.790 |
Why?
|
| Escherichia coli Proteins | 8 | 2010 | 133 | 1.460 |
Why?
|
| Escherichia coli | 13 | 2010 | 460 | 1.160 |
Why?
|
| Tetracycline Resistance | 6 | 2007 | 6 | 1.130 |
Why?
|
| Antibody Affinity | 2 | 2020 | 21 | 1.120 |
Why?
|
| Bacterial Proteins | 14 | 2017 | 595 | 1.120 |
Why?
|
| Fucosyltransferases | 5 | 2006 | 9 | 1.090 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 259 | 1.070 |
Why?
|
| Placenta | 4 | 2023 | 117 | 0.950 |
Why?
|
| Membrane Proteins | 6 | 2008 | 561 | 0.920 |
Why?
|
| R Factors | 4 | 2005 | 4 | 0.910 |
Why?
|
| Premature Birth | 2 | 2023 | 95 | 0.840 |
Why?
|
| Infant | 8 | 2023 | 1175 | 0.810 |
Why?
|
| Anti-Bacterial Agents | 5 | 2007 | 432 | 0.790 |
Why?
|
| Merozoite Surface Protein 1 | 4 | 2022 | 34 | 0.770 |
Why?
|
| Carrier Proteins | 7 | 2008 | 321 | 0.770 |
Why?
|
| Immunoglobulin M | 4 | 2022 | 86 | 0.750 |
Why?
|
| Macrolides | 3 | 2007 | 14 | 0.740 |
Why?
|
| Campylobacter coli | 3 | 2006 | 3 | 0.730 |
Why?
|
| Pregnancy | 8 | 2023 | 1772 | 0.720 |
Why?
|
| DNA, Bacterial | 8 | 2017 | 206 | 0.710 |
Why?
|
| Malaria | 1 | 2022 | 90 | 0.710 |
Why?
|
| Pregnancy Complications, Parasitic | 2 | 2018 | 10 | 0.710 |
Why?
|
| Cameroon | 8 | 2019 | 35 | 0.700 |
Why?
|
| Parasitemia | 2 | 2018 | 13 | 0.700 |
Why?
|
| Campylobacter Infections | 4 | 2006 | 8 | 0.590 |
Why?
|
| Protozoan Proteins | 2 | 2018 | 191 | 0.580 |
Why?
|
| Infant, Newborn | 5 | 2023 | 972 | 0.560 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 102 | 0.540 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 101 | 0.530 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 74 | 0.520 |
Why?
|
| Endemic Diseases | 1 | 2017 | 23 | 0.510 |
Why?
|
| Erythrocytes | 1 | 2017 | 126 | 0.510 |
Why?
|
| Sulfadoxine | 1 | 2015 | 6 | 0.480 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2005 | 203 | 0.480 |
Why?
|
| Pyrimethamine | 1 | 2015 | 10 | 0.480 |
Why?
|
| Humans | 32 | 2026 | 43102 | 0.480 |
Why?
|
| Monocytes | 1 | 2017 | 277 | 0.460 |
Why?
|
| Antimalarials | 1 | 2015 | 64 | 0.450 |
Why?
|
| Temperature | 6 | 2017 | 313 | 0.440 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 117 | 0.420 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2019 | 51 | 0.410 |
Why?
|
| Mutation | 7 | 2017 | 1177 | 0.410 |
Why?
|
| Molecular Sequence Data | 11 | 2005 | 1542 | 0.400 |
Why?
|
| Tellurium | 3 | 2003 | 5 | 0.400 |
Why?
|
| Young Adult | 9 | 2020 | 5080 | 0.390 |
Why?
|
| Microbial Sensitivity Tests | 8 | 2017 | 245 | 0.390 |
Why?
|
| Erythromycin | 3 | 2007 | 14 | 0.370 |
Why?
|
| Gene Transfer, Horizontal | 3 | 2009 | 24 | 0.370 |
Why?
|
| Female | 13 | 2023 | 24698 | 0.360 |
Why?
|
| Bacteria | 2 | 2006 | 293 | 0.360 |
Why?
|
| Base Sequence | 8 | 2017 | 983 | 0.350 |
Why?
|
| Adult | 11 | 2022 | 13872 | 0.350 |
Why?
|
| Ribosomes | 4 | 2005 | 35 | 0.320 |
Why?
|
| Polymerase Chain Reaction | 5 | 2019 | 455 | 0.310 |
Why?
|
| Merozoites | 2 | 2020 | 3 | 0.310 |
Why?
|
| Epitopes | 1 | 2010 | 157 | 0.300 |
Why?
|
| Immunoassay | 2 | 2020 | 74 | 0.300 |
Why?
|
| Salmonella typhi | 1 | 2009 | 33 | 0.300 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 16 | 0.290 |
Why?
|
| Transcription, Genetic | 3 | 2008 | 592 | 0.290 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 28 | 0.290 |
Why?
|
| Adolescent | 8 | 2020 | 6081 | 0.290 |
Why?
|
| Intestines | 1 | 2009 | 71 | 0.290 |
Why?
|
| Cell Membrane | 2 | 2008 | 403 | 0.270 |
Why?
|
| Interleukin-6 | 1 | 2009 | 165 | 0.270 |
Why?
|
| Fucose | 1 | 2006 | 4 | 0.250 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 82 | 0.250 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2007 | 57 | 0.250 |
Why?
|
| Carbohydrate Metabolism | 1 | 2006 | 26 | 0.250 |
Why?
|
| Liver Abscess | 1 | 2006 | 3 | 0.250 |
Why?
|
| Campylobacter | 1 | 2006 | 2 | 0.250 |
Why?
|
| Epithelial Cells | 2 | 2010 | 434 | 0.250 |
Why?
|
| Child, Preschool | 5 | 2019 | 1546 | 0.240 |
Why?
|
| Tendinopathy | 1 | 2026 | 5 | 0.240 |
Why?
|
| Tendons | 1 | 2026 | 10 | 0.240 |
Why?
|
| Poultry | 1 | 2006 | 13 | 0.240 |
Why?
|
| Cloning, Molecular | 5 | 2004 | 314 | 0.240 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 77 | 0.230 |
Why?
|
| Tetracyclines | 1 | 2005 | 2 | 0.230 |
Why?
|
| Catalytic Domain | 1 | 2006 | 118 | 0.230 |
Why?
|
| Plants | 1 | 2006 | 113 | 0.230 |
Why?
|
| Tyrosine | 1 | 2005 | 120 | 0.230 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2026 | 88 | 0.230 |
Why?
|
| DNA Primers | 4 | 2007 | 294 | 0.230 |
Why?
|
| Helicobacter Infections | 2 | 2005 | 86 | 0.220 |
Why?
|
| Serratia marcescens | 1 | 2004 | 3 | 0.220 |
Why?
|
| Diarrhea | 1 | 2005 | 95 | 0.220 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2004 | 3 | 0.220 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 8 | 0.220 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2005 | 186 | 0.220 |
Why?
|
| Male | 10 | 2026 | 23409 | 0.220 |
Why?
|
| Molecular Biology | 1 | 2004 | 47 | 0.210 |
Why?
|
| Virulence Factors | 1 | 2005 | 125 | 0.210 |
Why?
|
| Kanamycin Resistance | 1 | 2004 | 1 | 0.210 |
Why?
|
| Nucleotides | 1 | 2004 | 37 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 423 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2008 | 296 | 0.200 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2022 | 12 | 0.190 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 83 | 0.190 |
Why?
|
| Antibody Formation | 1 | 2022 | 76 | 0.190 |
Why?
|
| Middle Aged | 7 | 2020 | 12222 | 0.190 |
Why?
|
| Escherichia coli O157 | 1 | 2002 | 17 | 0.190 |
Why?
|
| Child | 5 | 2019 | 3443 | 0.190 |
Why?
|
| Microscopy | 2 | 2019 | 35 | 0.180 |
Why?
|
| Amino Acid Sequence | 4 | 2005 | 1180 | 0.180 |
Why?
|
| Operon | 3 | 2008 | 43 | 0.180 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2007 | 51 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2006 | 267 | 0.160 |
Why?
|
| Substrate Specificity | 3 | 2006 | 219 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2005 | 171 | 0.150 |
Why?
|
| Sulfhydryl Compounds | 1 | 1999 | 51 | 0.150 |
Why?
|
| Blood | 1 | 2019 | 37 | 0.150 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 68 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 458 | 0.140 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 144 | 0.140 |
Why?
|
| Transformation, Bacterial | 3 | 2005 | 12 | 0.140 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 36 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 3 | 2004 | 209 | 0.140 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2008 | 197 | 0.140 |
Why?
|
| Genotype | 3 | 2017 | 800 | 0.140 |
Why?
|
| Rifampin | 1 | 2017 | 8 | 0.140 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2017 | 22 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 74 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 2853 | 0.140 |
Why?
|
| Aged | 5 | 2019 | 8214 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 4 | 2003 | 515 | 0.140 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 35 | 0.130 |
Why?
|
| Microspheres | 1 | 2017 | 49 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 196 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2017 | 86 | 0.130 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 518 | 0.130 |
Why?
|
| RNA, Ribosomal, 23S | 2 | 2007 | 6 | 0.130 |
Why?
|
| Saliva | 1 | 2017 | 119 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 109 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 518 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2017 | 411 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2010 | 239 | 0.120 |
Why?
|
| Protein Conformation | 3 | 2008 | 416 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2007 | 127 | 0.120 |
Why?
|
| Bacterial Typing Techniques | 2 | 2006 | 37 | 0.120 |
Why?
|
| Placenta Diseases | 1 | 2015 | 5 | 0.120 |
Why?
|
| Insecticide-Treated Bednets | 1 | 2015 | 8 | 0.120 |
Why?
|
| Parity | 1 | 2015 | 59 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 153 | 0.120 |
Why?
|
| Open Reading Frames | 2 | 2008 | 79 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2015 | 104 | 0.120 |
Why?
|
| Cell Line | 3 | 2010 | 1410 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 135 | 0.110 |
Why?
|
| Biological Transport | 2 | 2007 | 204 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2006 | 181 | 0.110 |
Why?
|
| Virulence | 2 | 2005 | 246 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1081 | 0.100 |
Why?
|
| Animals | 7 | 2026 | 16992 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2004 | 272 | 0.100 |
Why?
|
| Kinetics | 2 | 2006 | 695 | 0.100 |
Why?
|
| Genetic Complementation Test | 2 | 2003 | 56 | 0.100 |
Why?
|
| Microbial Viability | 2 | 2017 | 42 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1285 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 3156 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 652 | 0.090 |
Why?
|
| Ligases | 1 | 2010 | 8 | 0.080 |
Why?
|
| Glycosyltransferases | 1 | 2010 | 9 | 0.080 |
Why?
|
| Papua New Guinea | 1 | 2010 | 21 | 0.080 |
Why?
|
| Colombia | 1 | 2010 | 31 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2010 | 87 | 0.080 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 132 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2010 | 206 | 0.080 |
Why?
|
| Caco-2 Cells | 1 | 2009 | 64 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2015 | 2544 | 0.070 |
Why?
|
| Alleles | 1 | 2010 | 352 | 0.070 |
Why?
|
| Peptide Elongation Factor G | 1 | 2008 | 1 | 0.070 |
Why?
|
| Cosmids | 1 | 2008 | 2 | 0.070 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2008 | 17 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 307 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2026 | 2157 | 0.070 |
Why?
|
| Gastric Mucosa | 2 | 2010 | 65 | 0.070 |
Why?
|
| Clarithromycin | 1 | 2007 | 9 | 0.070 |
Why?
|
| Dipeptides | 1 | 2007 | 31 | 0.070 |
Why?
|
| Guanosine Triphosphate | 1 | 2007 | 18 | 0.070 |
Why?
|
| Culture Media | 1 | 2007 | 96 | 0.070 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 43 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2007 | 64 | 0.070 |
Why?
|
| Hydrolysis | 1 | 2007 | 97 | 0.060 |
Why?
|
| Chromosomes, Bacterial | 1 | 2007 | 21 | 0.060 |
Why?
|
| Protein Transport | 1 | 2008 | 296 | 0.060 |
Why?
|
| Solubility | 1 | 2007 | 139 | 0.060 |
Why?
|
| Models, Molecular | 3 | 2008 | 876 | 0.060 |
Why?
|
| Light | 1 | 2007 | 185 | 0.060 |
Why?
|
| Binding Sites | 2 | 2005 | 671 | 0.060 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2026 | 20 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2007 | 182 | 0.060 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2005 | 1 | 0.060 |
Why?
|
| Oligosaccharides | 1 | 2006 | 29 | 0.060 |
Why?
|
| United States | 1 | 2017 | 5205 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 286 | 0.060 |
Why?
|
| Point Mutation | 1 | 2005 | 98 | 0.060 |
Why?
|
| Replicon | 1 | 2004 | 7 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2026 | 131 | 0.060 |
Why?
|
| Collagen | 1 | 2026 | 181 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2026 | 183 | 0.060 |
Why?
|
| Salmonella enterica | 1 | 2004 | 10 | 0.060 |
Why?
|
| Kanamycin Kinase | 1 | 2004 | 2 | 0.060 |
Why?
|
| Alberta | 1 | 2004 | 2 | 0.060 |
Why?
|
| Kanamycin | 1 | 2004 | 5 | 0.060 |
Why?
|
| DNA Gyrase | 1 | 2004 | 8 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 88 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2004 | 67 | 0.060 |
Why?
|
| RNA, Bacterial | 1 | 2004 | 40 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 458 | 0.050 |
Why?
|
| Bacterial Adhesion | 1 | 2004 | 41 | 0.050 |
Why?
|
| Coliphages | 1 | 2004 | 9 | 0.050 |
Why?
|
| Sweden | 1 | 2004 | 18 | 0.050 |
Why?
|
| Restriction Mapping | 1 | 2004 | 42 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2004 | 165 | 0.050 |
Why?
|
| Quinolines | 1 | 2004 | 78 | 0.050 |
Why?
|
| Egypt | 1 | 2004 | 54 | 0.050 |
Why?
|
| Cattle | 1 | 2005 | 498 | 0.050 |
Why?
|
| Food Microbiology | 1 | 2004 | 39 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2006 | 307 | 0.050 |
Why?
|
| Geography | 1 | 2004 | 110 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1070 | 0.050 |
Why?
|
| Canada | 1 | 2004 | 163 | 0.050 |
Why?
|
| Proteus mirabilis | 1 | 2003 | 3 | 0.050 |
Why?
|
| Lac Repressors | 1 | 2003 | 8 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2003 | 27 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 92 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 20 | 0.050 |
Why?
|
| Tetracycline | 1 | 2003 | 17 | 0.050 |
Why?
|
| Protein Binding | 2 | 2005 | 1082 | 0.050 |
Why?
|
| DNA Damage | 1 | 2005 | 356 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 526 | 0.050 |
Why?
|
| DNA Repair | 1 | 2004 | 198 | 0.050 |
Why?
|
| Shiga Toxin | 1 | 2002 | 5 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 125 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 457 | 0.050 |
Why?
|
| Metronidazole | 1 | 2002 | 16 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 561 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2002 | 148 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2003 | 190 | 0.040 |
Why?
|
| Phenotype | 2 | 2017 | 780 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2003 | 273 | 0.040 |
Why?
|
| Electrophoresis, Capillary | 1 | 1999 | 20 | 0.040 |
Why?
|
| Mice | 3 | 2026 | 6644 | 0.040 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 1999 | 12 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 1999 | 27 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 712 | 0.040 |
Why?
|
| Time Factors | 1 | 2003 | 1857 | 0.040 |
Why?
|
| Isoniazid | 1 | 2017 | 6 | 0.030 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 6 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2017 | 91 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 611 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 238 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 195 | 0.030 |
Why?
|
| Paraquat | 2 | 2005 | 20 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 2005 | 190 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1612 | 0.020 |
Why?
|
| O Antigens | 1 | 2010 | 7 | 0.020 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2010 | 6 | 0.020 |
Why?
|
| Peptidyl Transferases | 1 | 2010 | 3 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 31 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 113 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 883 | 0.010 |
Why?
|
| Oxidants | 1 | 2005 | 42 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2005 | 39 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 2005 | 20 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 54 | 0.010 |
Why?
|
| Guanine | 1 | 2005 | 44 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 168 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 218 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 2005 | 129 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 301 | 0.010 |
Why?
|
| Gastric Acidity Determination | 1 | 2003 | 3 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2005 | 570 | 0.010 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 98 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 592 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2002 | 155 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 1869 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1596 | 0.010 |
Why?
|